Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...

Avenacy’s Doxycycline for Injection, USP is available in 100 mg single-dose vials ... Avenacy is a U.S.-based specialty pharmaceutical company focused on supplying critical injectable medications used ...

It’s GlycoEra’s time to shine. The biotech has closed a series B fundraise clocking in at $130 million, with the funds set to ...

Merck (MRK) stock falls as the company withdraws U.S. marketing application for lung cancer therapy HER3-DXd developed with ...

A therapy at the center of their $22 billion alliance failed to extend survival in a type of lung tumor, leading the ...

Buried in the DNA of the long extinct woolly mammoth is a compound that scientists hope will one day yield a lifesaving ...

On Saturday, the Stanford Students in Biodesign and Biopharma (SSB) hosted “Impulse,” among Stanford’s premier biotechnology conferences, bringing together a community of students building ...

Roche said on it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the third and last phase of testing on humans.

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

Just a few months after raising $200 million in third-round financing, immunology specialist Zenas BioPharma has filed an initial public offering in the US seeking to add another $100 million to ...

It also claims that Ultragenyx was aware of the origins of the HeLa cell line, but never sought or received permission from the estate of Henrietta Lacks to use them. The biotech – which has a ...